Welcome to our dedicated page for DENTSPLY SIRONA news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on DENTSPLY SIRONA stock.
DENTSPLY SIRONA Inc. (symbol: XRAY) stands as the world’s largest manufacturer of professional dental products and technologies. As a global total solutions provider, Dentsply Sirona empowers dental professionals to offer better, safer, and faster dental care. The company’s extensive portfolio includes leading positions in consumables, equipment, technology, and specialty products. Dentsply Sirona is committed to innovation and quality, reflected in its comprehensive end-to-end solutions offering, which spans well-known and established brands in the industry.
Dentsply Sirona emerged from a merger between Dentsply International and Sirona Dental Systems in 2016. Today, the company manufactures and markets a complete range of dental and oral health products, including dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation.
Recently, Dentsply Sirona has announced enhancements to its DS Core platform, a cloud-based solution supporting dental professionals throughout the entire treatment continuum. The platform now boasts improved patient communication tools, a unified ordering system, and support for additional data formats, making it easier for dental practices to collaborate with labs and service providers.
Financially, Dentsply Sirona maintains a robust presence in the dental industry, with significant revenue generated through third-party distributors and direct sales to labs, offices, and consumers. The company’s ongoing commitment to innovation is further demonstrated by its DS World Las Vegas event, an annual gathering that provides dental professionals with market-leading education, networking opportunities, and exposure to the latest dental technologies.
With its headquarters in Charlotte, North Carolina, Dentsply Sirona continues to shape the future of dentistry, striving to enhance patient care and advance dental practices through its unwavering dedication to quality and innovation. For more information on Dentsply Sirona and its products, visit the official website.
WellAir announced the appointment of Kari Dixon as President and CEO, effective immediately, succeeding Todd M. Pope, who will serve as Vice-Chair of the Board. Dixon, previously WellAir's CFO, possesses extensive experience in capital markets and financial planning, having worked with Dentsply Sirona and Form Technologies. Todd highlighted WellAir's advancements, including the launch of the FDA cleared Defend 400 air cleaning solution. Dixon aims to drive growth in the indoor air quality sector, emphasizing its significance in community wellness.
Dentsply Sirona has appointed John Groetelaars as Interim CEO following the termination of Don Casey. The Board is actively seeking a new CEO with a focus on driving operational excellence. Additionally, Barbara Bodem has been named Interim CFO to ensure a smooth transition after the departure of Jorge Gomez. Dentsply Sirona anticipates first quarter net sales of approximately $965 million, indicating a 1.4% decline year-over-year, affected by weaker U.S. sales and supply chain challenges. Further financial details will be disclosed on May 5, 2022.
Dentsply Sirona (Nasdaq: XRAY) has announced the resignation of Chief Financial Officer Jorge Gomez, effective May 6, 2022. Gomez, who joined the company in 2019, will take on a CFO role at another public company. The firm is now beginning the search for his replacement. CEO Don Casey expressed gratitude for Gomez’s contributions, notably in enhancing the Finance and IT sectors and improving the company's ESG initiatives. Dentsply Sirona maintains its status as the largest manufacturer of dental products and technologies worldwide.
Dentsply Sirona (Nasdaq: XRAY) has appointed John P. Groetelaars to its Board of Directors, expanding the board from eleven to twelve members. Groetelaars brings over 30 years of experience in MedTech, including his role as former CEO of Hillrom, where he led a $3 billion revenue organization. His leadership in transforming business strategies and promoting diversity initiatives positions him as a valuable asset to the board. Dentsply Sirona aims to enhance patient care through innovative dental solutions with his guidance.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call on May 5, 2022, at 8:30 am ET to discuss its financial results. Investors can access a presentation on the company's website. The live webcast will also be available through the Investors section. Participants can join by dialing +1-877-370-7637 for domestic or +1-629-228-0723 for international calls, using Conference ID # 7888396. A replay will be accessible for one week post-call. Dentsply Sirona is a leading global manufacturer of dental products, known for its commitment to innovation and quality.
Dentsply Sirona, the world’s largest manufacturer of dental products, will participate in the Piper Sandler Virtual Dental Day. CEO Don Casey will lead a fireside chat on March 29, 2022, at 1:00 pm ET. The event will be accessible via a live webcast on the Dentsply Sirona Investors website. A replay will be available for 30 days post-discussion. Dentsply Sirona, listed on Nasdaq under the symbol XRAY, has a rich 135-year heritage in dental innovation, providing high-quality products to enhance patient care.
Dentsply Sirona (NASDAQ: XRAY) announced an accelerated share repurchase agreement totaling $150 million with Bank of America to repurchase its common stock. The initial delivery will be approximately 2.4 million shares, with final share count depending on the average stock prices during the valuation period. The ASR is expected to conclude by the end of Q2 2022, pending acceleration adjustments. This move aims to enhance shareholder value within Dentsply Sirona's current buyback authorization.
Dentsply Sirona reported strong FY21 results, with net sales of $4,251 million, a 27.2% increase year-over-year. Operating income rose to $622 million, and adjusted EPS reached $2.87, up 60.3%. However, Q4 sales were flat at $1,088 million, with adjusted EPS dropping 12.6% to $0.76. For FY22, the company forecasts organic sales growth of 4% to 5% and adjusted EPS between $3.05 and $3.25. CEO Don Casey emphasized their optimistic outlook based on a robust innovation pipeline and strategic partnerships.
Dentsply Sirona (Nasdaq: XRAY) is set to unveil a collaboration with Google Cloud and its new 3D printing solution, Primeprint, on March 4, during a virtual global event. This partnership aims to enhance digital dentistry by improving workflows for dentists and labs. Key principles include secure data sharing and high-quality 3D visualization. Primeprint represents a significant advancement in 3D printing technology for dental applications, offering automated processes and regulatory compliance for medical products. The innovations aim to empower dental professionals and improve patient care.
Dentsply Sirona (Nasdaq: XRAY) announced the appointment of Dr. Dorothea Wenzel to its Board of Directors, increasing the board size from ten to eleven members. Dr. Wenzel brings extensive experience from her previous role as Executive Vice President at Merck KGaA, enhancing the board's international perspective. Her background in healthcare and finance is expected to support Dentsply Sirona's vision to advance dentistry and improve oral health globally.
FAQ
What is the current stock price of DENTSPLY SIRONA (XRAY)?
What is the market cap of DENTSPLY SIRONA (XRAY)?
What does Dentsply Sirona Inc. do?
What is DS Core?
When was Dentsply Sirona formed?
Where is Dentsply Sirona headquartered?
What event does Dentsply Sirona host annually?
How can I learn more about Dentsply Sirona's products?
What kind of products does Dentsply Sirona offer?
What is the significance of Dentsply Sirona in the dental industry?
How does Dentsply Sirona distribute its products?
What recent updates has Dentsply Sirona announced?
